Israel Makov was credited with Teva’s emergence as a global company, steering the company through over 12 acquisitions in his five-year tenure
The Board of Directors of Sun Pharmaceutical Industries announced the appointment of Israel Makov, as Chairman of the Board.
Makov was the President and Chief Executive Officer, Teva Pharmaceutical Industries from 2002-2007. Among Israel’s most respected corporate leaders, he is credited with Teva’s emergence as a global company, steering the company through over 12 acquisitions, two of which are regarded as the largest M&A deals in Israeli history at the time.
Welcoming Makov to the Board, Dilip Shanghvi, Managing Director, Sun Pharma said, “He is an exceptional leader with deep knowledge and experience in globalising businesses successfully. As Sun Pharma continues to rapidly expand its presence worldwide, I am sure that we will benefit immensely from his experience.”
On his appointment, Makov said, “I am happy to accept the position of Chairman of the Board. Sun Pharma is an exciting company poised for substantial global expansion and I look forward to working together with Dilip and his team in realising their visionary goals.” Under Makov’s leadership, Teva became the undisputed global leader in generic pharma industry and a global leader in the treatment of multiple sclerosis. Prior to joining Teva in 1995, Makov led a number of companies in various industries, and founded Israel’s first biotech company, Interpharm which went public in the US as the first Israeli company in R&D stage.
Currently, Makov is Chairman of Given Imaging – the pioneer developer and world’s leading provider of capsule endoscopy, Chairman of BIOLIGHT – a life sciences investment company, Chairman of Micromedic Technologies – a cluster of companies engaged in cancer diagnostics, and Chairman of Eltav – the pioneer and world leader in wireless monitoring of industrial valves. Until recently, Makov was Chairman of Netafim – the global leader in smart irrigation solutions. Makov is also a member of the Board of Directors of the Israel National Nanotechnology Initiative; a member of the Executive Board & Management Committee of the Weizmann Institute of Science and on the Board of Governors of the Technion – Israel Institute of Technology.